Indoor air-related effects and airborne (1→3)-β-D-glucan

Environmental Health Perspectives

Volumn 107, Issue SUPPL. 3, 1999, Pages 501-503

  Rylander, Ragnar ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

(1 3) D glucan; Airways inflammation; Indoor air; Molds

Indexed keywords

GLUCAN; MARKER;

AIRBORNE PARTICLE; AMBIENT AIR; BIOMASS; CONFERENCE PAPER; ENVIRONMENTAL EXPOSURE; HUMAN; INFLAMMATION; MOULD; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK; SYMPTOM;

EID: 0032791064     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.99107s3501     Document Type: Conference Paper

References (19)

1. Burge PS, Hedge A, Wilson S, Bass JH, Robertson A. Sick buildings syndrome: A study of 4373 office workers. Ann Occup Hyg 31:493-504 (1987).
2. Samet JM, Spengler JD. Indoor Air Pollution - A Health Perspective. Baltimore:Johns Hopkins University Press, 1991.
3. Rylander R. Sick building syndrome. In: XVI European Congress of Allergology and Clinical Immunology (Basomba A, Sastre J, eds). Madrid:Monduzzi Editore, 1995;409-414.
4. Husman T. Health effects of indoor-air microorganisms. Scand J Work Environ Health 22:5-13 (1996).
5. Rylander R. Are effects after mold exposure caused by specific agents? Proceedings of the Third International Conference on Bioaerosols, Funji and Mycotoxins, September 1998, Sarasoda Springs, NY, in press.
6. Rylander R, ed. Endotoxins in the environment: a criteria document. Int J Occup Environ Health 3:S1-S48 (1997).
7. Miller JD, Young JC. The use of ergosterol to measure exposure to fungal propagules. Am Ind Hyg Assoc J 58:39-43 (1997).
8. Rylander R. Investigations of the relationship between disease and airborne (1→3)-β-D-glucan in buildings. Mediators Inflamm 6:275-277 (1997).
9. Tamura H, Arimoto Y, Tanaka S, Yoshida S, Obayashi T, Kawai T. Automated kinetic assay for endotoxin and (1→3)-β-D-glucan in human blood. Clinica Chimica Acta 226:109-112 (1994).
10. Douewes J, Doekes G, Montijn R, Heederik D, Brunekreef B. An immunoassay for the measurement of (1→3)-β-D-glucans in the indoor environment. Mediators Inflamm 6:257-262 (1997).
11. Rylander R, Sörensen S, Goto H, Yuasa K, Tanaka S. The importance of endotoxin and glucan for symptoms in sick buildings. In: Present and Future of Indoor Air Quality (Bieva CJ, Courtois Y, Govaerts M, eds). Amsterdam: Excerpta Medica, 1989;219-226.
12. Rylander R, Persson K, Goto H, Yuasa K, Tanaka S. Airborne β,1-3 glucan may be related to symptoms in sick buildings. Indoor Environ 1:263-267 (1992).
13. Rylander R, Hsieh V, Courteheuse C. The first case of sick building syndrome in Switzerland. Indoor Environ 3:159-162 (1994).
14. Rylander R, Fogelmark B, Danielsson B. (1→3)-β-D-glucan in indoor environment induced airways inflammation [in Swedish]. Läkartidningen 95:1562-1563 (1998).
15. Rylander R. Airborne (1→3)-β-D-glucan and airway effects in a day care center before and after renovation. Arch Environ Health 52: 281-285 (1997).
16. Thorn J, Rylander R. Airways inflammation and glucan in a rowhouse area. Am J Respir Crit Care Med 157:1798-1803 (1998).
17. Beijer L, Thorn J, Rylander R. Inhalation of (1→3)-β-D-glucan in humans. In: Proceedings of the 22nd Cotton and Other Organic Dusts Research Conference, 8-9 January 1998, San Diego, California. Memphis, TN:National Cotton Council 1998; 251-253.
18. Rylander R, Norrhall M, Engdahl U, Tunsäter A, Holt PG. Airways inflammation, atopy, and (1→3)-β-D-glucan exposure in two schools. Am J Respir Crit Care Med 158:1685-1687 (1998).
19. Airway responsiveness and chest symptoms after inhalation of endotoxin (1→3)-β-D-glucan. Indoor Built Environ 5:106-111 (1996).